GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » Net Margin %

Theralase Technologies (TSXV:TLT) Net Margin % : -272.25% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Theralase Technologies's Net Income for the three months ended in Dec. 2023 was C$-0.99 Mil. Theralase Technologies's Revenue for the three months ended in Dec. 2023 was C$0.36 Mil. Therefore, Theralase Technologies's net margin for the quarter that ended in Dec. 2023 was -272.25%.

The historical rank and industry rank for Theralase Technologies's Net Margin % or its related term are showing as below:

TSXV:TLT' s Net Margin % Range Over the Past 10 Years
Min: -769.09   Med: -347.48   Max: -187.4
Current: -400.94


TSXV:TLT's Net Margin % is ranked worse than
87.07% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: -1.675 vs TSXV:TLT: -400.94

Theralase Technologies Net Margin % Historical Data

The historical data trend for Theralase Technologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Net Margin % Chart

Theralase Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -769.09 -602.69 -564.79 -459.61 -427.20

Theralase Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -538.31 -270.86 -680.68 -361.57 -272.25

Competitive Comparison of Theralase Technologies's Net Margin %

For the Medical Devices subindustry, Theralase Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theralase Technologies's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Net Margin % falls into.



Theralase Technologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Theralase Technologies's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4.571/1.07
=-427.20 %

Theralase Technologies's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.991/0.364
=-272.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theralase Technologies  (TSXV:TLT) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Theralase Technologies Net Margin % Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Theralase Technologies (TSXV:TLT) Business Description

Traded in Other Exchanges
Address
41 Hollinger Road, Toronto, ON, CAN, M4B 3G4
Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.
Executives
Matthew Thomas Perraton Director

Theralase Technologies (TSXV:TLT) Headlines

From GuruFocus

Top 5 3rd Quarter Trades of Strong Tower Advisory Services

By GuruFocus Research GuruFocus Editor 10-15-2022

Top 5 4th Quarter Trades of Financial Sense Advisors, Inc.

By GuruFocus Research GuruFocus Editor 02-07-2023

Top 5 4th Quarter Trades of VANTAGEPOINT INVESTMENT ADVISERS LLC

By GuruFocus Research GuruFocus Editor 01-24-2023

Rafferty Asset Management, LLC's Top 5 Buys of the 4th Quarter

By GuruFocus Research GuruFocus Editor 02-15-2023

Top 5 4th Quarter Trades of ONE PLUS ONE WEALTH MANAGEMENT, LLC

By GuruFocus Research GuruFocus Editor 01-19-2023

Top 5 4th Quarter Trades of Starfox Financial Services, LLC

By GuruFocus Research GuruFocus Editor 02-08-2023

Top 5 2nd Quarter Trades of K.J. Harrison & Partners Inc

By GuruFocus Research GuruFocus Editor 07-27-2022

Top 5 2nd Quarter Trades of Louis Moore Bacon

By GuruFocus Research GuruFocus Editor 08-15-2022

Top 5 2nd Quarter Trades of SYNOVUS FINANCIAL CORP

By GuruFocus Research GuruFocus Editor 08-11-2022